X-71147842-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_181303.2(NLGN3):​c.93G>C​(p.Leu31Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000183 in 1,094,772 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 0.0000018 ( 0 hom. 0 hem. )

Consequence

NLGN3
NM_181303.2 missense

Scores

17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.89

Publications

0 publications found
Variant links:
Genes affected
NLGN3 (HGNC:14289): (neuroligin 3) This gene encodes a member of a family of neuronal cell surface proteins. Members of this family may act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses. Mutations in this gene may be associated with autism and Asperger syndrome. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Oct 2009]
NLGN3 Gene-Disease associations (from GenCC):
  • autism, susceptibility to, X-linked 1
    Inheritance: Unknown, XL Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: MODERATE Submitted by: Illumina, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22414586).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NLGN3NM_181303.2 linkc.93G>C p.Leu31Phe missense_variant Exon 2 of 8 ENST00000358741.4 NP_851820.1 Q9NZ94-1X5DNV3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NLGN3ENST00000358741.4 linkc.93G>C p.Leu31Phe missense_variant Exon 2 of 8 5 NM_181303.2 ENSP00000351591.4 Q9NZ94-1
NLGN3ENST00000685718.1 linkn.93G>C non_coding_transcript_exon_variant Exon 2 of 8 ENSP00000510514.1 A0A8I5QJU7

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD2 exomes
AF:
0.00000573
AC:
1
AN:
174375
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000372
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000183
AC:
2
AN:
1094772
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
360362
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26341
American (AMR)
AF:
0.0000572
AC:
2
AN:
34960
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19313
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30080
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53464
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40226
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4131
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
840310
Other (OTH)
AF:
0.00
AC:
0
AN:
45947
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
23
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Feb 21, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.93G>C (p.L31F) alteration is located in exon 2 (coding exon 1) of the NLGN3 gene. This alteration results from a G to C substitution at nucleotide position 93, causing the leucine (L) at amino acid position 31 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Mar 22, 2023
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
16
DANN
Benign
0.92
DEOGEN2
Benign
0.20
.;.;.;T
FATHMM_MKL
Benign
0.66
D
LIST_S2
Benign
0.83
T;T;T;T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.22
T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.96
L;.;L;L
PhyloP100
2.9
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-1.2
N;N;N;N
REVEL
Benign
0.12
Sift
Benign
0.33
T;T;T;T
Sift4G
Benign
0.51
T;T;T;T
Polyphen
0.0010
.;.;B;.
Vest4
0.072
MutPred
0.67
Gain of methylation at R34 (P = 0.1122);Gain of methylation at R34 (P = 0.1122);Gain of methylation at R34 (P = 0.1122);Gain of methylation at R34 (P = 0.1122);
MVP
0.59
MPC
0.74
ClinPred
0.084
T
GERP RS
3.9
Varity_R
0.20
gMVP
0.23
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1258826819; hg19: chrX-70367692; API